Title : Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway.

Pub. Date : 2022 Jan-Dec

PMID : 35234063






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the HepG2 xenografts model, sorafenib plus SDC exhibited greater suppression on tumor growth than individual treatment accompanied with decreased expression of VEGF, VEGFA, Ki67, CD31 and increased expression of caspase-3. Sorafenib vascular endothelial growth factor A Homo sapiens
2 In the HepG2 xenografts model, sorafenib plus SDC exhibited greater suppression on tumor growth than individual treatment accompanied with decreased expression of VEGF, VEGFA, Ki67, CD31 and increased expression of caspase-3. Sorafenib vascular endothelial growth factor A Homo sapiens